Literature DB >> 28470168

Anxiety disorders.

Michelle G Craske1, Murray B Stein2,3, Thalia C Eley4, Mohammed R Milad5,6, Andrew Holmes7, Ronald M Rapee8, Hans-Ulrich Wittchen9.   

Abstract

Anxiety disorders constitute the largest group of mental disorders in most western societies and are a leading cause of disability. The essential features of anxiety disorders are excessive and enduring fear, anxiety or avoidance of perceived threats, and can also include panic attacks. Although the neurobiology of individual anxiety disorders is largely unknown, some generalizations have been identified for most disorders, such as alterations in the limbic system, dysfunction of the hypothalamic-pituitary-adrenal axis and genetic factors. In addition, general risk factors for anxiety disorders include female sex and a family history of anxiety, although disorder-specific risk factors have also been identified. The diagnostic criteria for anxiety disorders varies for the individual disorders, but are generally similar across the two most common classification systems: the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and the International Classification of Diseases, Tenth Edition (ICD-10). Despite their public health significance, the vast majority of anxiety disorders remain undetected and untreated by health care systems, even in economically advanced countries. If untreated, these disorders are usually chronic with waxing and waning symptoms. Impairments associated with anxiety disorders range from limitations in role functioning to severe disabilities, such as the patient being unable to leave their home.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28470168     DOI: 10.1038/nrdp.2017.24

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   52.329


  113 in total

1.  Effects of N-acetylcysteine amide on anxiety and stress behavior in zebrafish.

Authors:  Carlos G Reis; Ricieri Mocelin; Radharani Benvenutti; Matheus Marcon; Adrieli Sachett; Ana P Herrmann; Elaine Elisabetsky; Angelo Piato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-11-25       Impact factor: 3.000

Review 2.  Modulation of the Endocannabinoid and Oxytocinergic Systems as a Potential Treatment Approach for Social Anxiety Disorder.

Authors:  Rafael Guimarães Dos Santos; Flávia de Lima Osório; Rocio Martin-Santos; Antonio Waldo Zuardi; Jaime Eduardo Cecilio Hallak; José Alexandre S Crippa
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

3.  Chronic stress dysregulates amygdalar output to the prefrontal cortex.

Authors:  Emily G Lowery-Gionta; Nicole A Crowley; Olena Bukalo; Shana Silverstein; Andrew Holmes; Thomas Louis Kash
Journal:  Neuropharmacology       Date:  2018-06-28       Impact factor: 5.250

4.  Social context and the real-world consequences of social anxiety.

Authors:  Juyoen Hur; Kathryn A DeYoung; Samiha Islam; Allegra S Anderson; Matthew G Barstead; Alexander J Shackman
Journal:  Psychol Med       Date:  2019-08-19       Impact factor: 7.723

5.  Early Childhood Predictors of Anxiety in Early Adolescence.

Authors:  Jennifer L Hudson; Kou Murayama; Lotte Meteyard; Talia Morris; Helen F Dodd
Journal:  J Abnorm Child Psychol       Date:  2019-07

6.  Prefrontal Executive Control Rescues Risk for Anxiety Associated with High Threat and Low Reward Brain Function.

Authors:  Matthew A Scult; Annchen R Knodt; Spenser R Radtke; Bartholomew D Brigidi; Ahmad R Hariri
Journal:  Cereb Cortex       Date:  2019-01-01       Impact factor: 5.357

7.  A Shift in the Activation of Serotonergic and Non-serotonergic Neurons in the Dorsal Raphe Lateral Wings Subnucleus Underlies the Panicolytic-Like Effect of Fluoxetine in Rats.

Authors:  Heloisa Helena Vilela-Costa; Ailton Spiacci; Isabella Galante Bissolli; Hélio Zangrossi
Journal:  Mol Neurobiol       Date:  2019-03-07       Impact factor: 5.590

8.  Dispositional negativity, cognition, and anxiety disorders: An integrative translational neuroscience framework.

Authors:  Juyoen Hur; Melissa D Stockbridge; Andrew S Fox; Alexander J Shackman
Journal:  Prog Brain Res       Date:  2019-04-17       Impact factor: 2.453

Review 9.  Preventive and Therapeutic Potential of Vitamin C in Mental Disorders.

Authors:  Qian-Qian Han; Tian-Tian Shen; Fang Wang; Peng-Fei Wu; Jian-Guo Chen
Journal:  Curr Med Sci       Date:  2018-03-15

Review 10.  The Good, the Bad and the Unknown Aspects of Ghrelin in Stress Coping and Stress-Related Psychiatric Disorders.

Authors:  Eva Maria Fritz; Nicolas Singewald; Dimitri De Bundel
Journal:  Front Synaptic Neurosci       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.